<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0192030.ref004">
 <label>4</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Abdool Karim</surname>
   <given-names>SS</given-names>
  </name>, 
  <name>
   <surname>Naidoo</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Grobler</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Padayatchi</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Baxter</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Gray</surname>
   <given-names>AL</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy</article-title>. 
  <source>The New England journal of medicine</source>. 
  <year>2010</year>;
  <volume>362</volume>:
  <fpage>697</fpage>â€“
  <lpage>706</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa0905848" xmlns:xlink="http://www.w3.org/1999/xlink">10.1056/NEJMoa0905848</ext-link>
  </comment>
  <?supplied-pmid 20181971?>
  <pub-id pub-id-type="pmid">20181971</pub-id>
 </mixed-citation>
</ref>
